AllianceBernstein
ATOS icon

AllianceBernstein’s Atossa Therapeutics ATOS Stock Holding History

AllianceBernstein’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,159
Closed -$11.7K – 3240
2025
Q1 		$11.7K Hold
1,159
– – ﹤0.01% 3190
2024
Q4 		$16.4K Hold
1,159
– – ﹤0.01% 3216
2024
Q3 		$26.4K Hold
1,159
– – ﹤0.01% 3214
2024
Q2 		$20.7K Buy
+1,159
New +$25.6K ﹤0.01% 3222
2022
Q2 		– Sell
-7,767
Closed -$146K – 3269
2022
Q1 		$146K Buy
7,767
+27
+0.3% +$549 ﹤0.01% 3060
2021
Q4 		$186K Hold
7,740
– – ﹤0.01% 3091
2021
Q3 		$378K Hold
7,740
– – ﹤0.01% 2868
2021
Q2 		$734K Buy
+7,740
New +$410K ﹤0.01% 2651

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return